(Q47209788)

11 January 2018

title

Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants (English)

1 reference

11 January 2018

1 reference

Jacqueline K Schneider

series ordinal

1

1 reference

11 January 2018

Debra K Gardner

series ordinal

2

1 reference

11 January 2018

Leandro Cordero

series ordinal

3

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 November 2008

1 reference

11 January 2018

published in

Pharmacotherapy

1 reference

11 January 2018

volume

28

1 reference

11 January 2018

issue

11

1 reference

11 January 2018

page(s)

1335-1340

1 reference

11 January 2018

Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

Screening examination of premature infants for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

Oxidative stress in the newborn--a 30-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1335

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.11.1335

1 reference

11 January 2018

1 reference

11 January 2018